458 related articles for article (PubMed ID: 21212173)
1. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
[TBL] [Abstract][Full Text] [Related]
2. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
4. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
7. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
[TBL] [Abstract][Full Text] [Related]
10. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
[TBL] [Abstract][Full Text] [Related]
12. Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats.
Mysona BA; Al-Gayyar MM; Matragoon S; Abdelsaid MA; El-Azab MF; Saragovi HU; El-Remessy AB
Diabetologia; 2013 Oct; 56(10):2329-39. PubMed ID: 23918145
[TBL] [Abstract][Full Text] [Related]
13. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
[TBL] [Abstract][Full Text] [Related]
14. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
Xu HZ; Le YZ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
[TBL] [Abstract][Full Text] [Related]
15. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
16. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.
El-Remessy AB; Al-Shabrawey M; Khalifa Y; Tsai NT; Caldwell RB; Liou GI
Am J Pathol; 2006 Jan; 168(1):235-44. PubMed ID: 16400026
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.
Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A
Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
